The Multinational Association for Supportive Care in Cancer (MASCC) risk index score: 10 years of use for identifying low-risk febrile neutropenic cancer patients
- 27 February 2013
- journal article
- review article
- Published by Springer Science and Business Media LLC in Supportive Care in Cancer
- Vol. 21 (5), 1487-1495
- https://doi.org/10.1007/s00520-013-1758-y
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- Febrile neutropenia in EDs: the role of an electronic clinical practice guidelineThe American Journal of Emergency Medicine, 2012
- Parental Perspectives on Inpatient Versus Outpatient Management of Pediatric Febrile NeutropeniaJournal of Pediatric Oncology Nursing, 2011
- Cost effectiveness of outpatient treatment for febrile neutropaenia in adult cancer patientsBritish Journal of Cancer, 2011
- Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2011
- Predicting febrile neutropenic patients at low risk using the MASCC score: does bacteremia matter?Supportive Care in Cancer, 2010
- Advances in the treatment of neutropeniaCurrent Opinion in Supportive & Palliative Care, 2009
- [Empirical antibiotic therapy for febrile neutropenia].2008
- 2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with CancerClinical Infectious Diseases, 2002
- A Double-Blind Comparison of Empirical Oral and Intravenous Antibiotic Therapy for Low-Risk Febrile Patients with Neutropenia during Cancer ChemotherapyThe New England Journal of Medicine, 1999
- Empiric Treatment of Infections in Neutropenic Patients with CancerClinical Infectious Diseases, 1983